ICON plc (ICLR) Earnings Call Analysis

NASDAQ · Healthcare · Diagnostics & Research

14/25

Growth 2 Margin 1 Expansion 5 Platform 1 Financial 5

latest quarter score

Earnings Reports

14
ICON (ICLR) Q2 2026: Bookings Surge 24% as Pass-Throughs Drive Revenue Mix Shift
July 30, 2026
19
ICON (ICLR) Q1 2026: Net Bookings Surge 42% as Commercial Strategy Drives Pipeline Quality
June 24, 2026
12
ICON (ICLR) Q4 2025: $3.9B Backlog Reset Reshapes Visibility as Margins Reset 150bps Lower
May 29, 2026
14
ICON (ICLR) Q3 2025: $900M Cancellations Cap Margin as Tech Investments Offset Pricing Pressure
October 23, 2025
16
ICON (ICLR) Q2 2025: Gross Business Awards Jump 11%, Biotech Wins Fuel Pipeline Despite Cancellation Drag
July 24, 2025
12
ICON (ICLR) Q1 2025: $350M COVID Trial Cancellations Underscore Persistent Biotech Volatility
July 04, 2025

Browse all companies